HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukihiko Shirayama Selected Research

Bipolar Disorder (Manic Depressive Psychosis)

12/2018Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukihiko Shirayama Research Topics

Disease

22Schizophrenia (Dementia Praecox)
01/2021 - 11/2002
8Cognitive Dysfunction
02/2019 - 05/2008
7Psychotic Disorders (Schizoaffective Disorder)
12/2021 - 06/2005
4Major Depressive Disorder (Major Depressive Disorders)
12/2018 - 01/2013
4Inflammation (Inflammations)
10/2018 - 10/2014
3Treatment-Resistant Depressive Disorder
10/2018 - 12/2014
2Tardive Dyskinesia
12/2021 - 10/2017
2Mental Disorders (Mental Disorder)
12/2018 - 10/2007
1Treatment-Resistant Schizophrenia
12/2021
1Thymoma (Thymic Carcinoma)
01/2021
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2020
1Alzheimer Disease (Alzheimer's Disease)
02/2019
1Bipolar Disorder (Manic Depressive Psychosis)
12/2018
1Mood Disorders (Mood Disorder)
01/2017
1Infections
01/2017
1Movement Disorders (Movement Disorder)
12/2015
1Memory Disorders (Memory Loss)
12/2014
1Gambling (Pathological Gambling)
12/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2014
1Brain Infarction
11/2011
1Genetic Translocation (Chromosomal Translocation)
02/2011
1Schizotypal Personality Disorder
02/2011
1Chromosome Aberrations (Chromosome Abnormalities)
02/2011
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2008
1Hypothermia
06/2008
1Hypersensitivity (Allergy)
09/2006
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2006
1Substance-Related Disorders (Drug Abuse)
06/2005
1Depressive Disorder (Melancholia)
01/2004
1Hallucinations (Hallucination)
09/2003

Drug/Important Bio-Agent (IBA)

6Dopamine (Intropin)FDA LinkGeneric
12/2021 - 06/2005
6Antidepressive Agents (Antidepressants)IBA
10/2018 - 01/2004
6Pharmaceutical PreparationsIBA
01/2017 - 09/2007
5Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 08/2004
3Proteins (Proteins, Gene)FDA Link
12/2018 - 07/2007
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2018 - 04/2008
3Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2014 - 12/2011
3Fluvoxamine (Luvox)FDA LinkGeneric
10/2012 - 05/2008
23-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2021 - 12/2020
2InflammasomesIBA
12/2020 - 11/2016
2Donepezil (Aricept)FDA LinkGeneric
02/2019 - 07/2009
2Glutamine (L-Glutamine)FDA Link
01/2017 - 07/2008
2Glutamic Acid (Glutamate)FDA Link
01/2017 - 07/2008
2Biomarkers (Surrogate Marker)IBA
07/2014 - 02/2014
2Sigma-1 ReceptorIBA
10/2012 - 05/2008
2Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2011 - 06/2008
2Risperidone (Risperdal Consta)FDA LinkGeneric
06/2010 - 09/2003
2Methamphetamine (Desoxyn)FDA LinkGeneric
07/2007 - 06/2005
1Protein Kinases (Protein Kinase)IBA
01/2021
13,4-Dihydroxyphenylacetic AcidIBA
01/2021
1Homovanillic AcidIBA
01/2021
1Glycogen Synthase (Synthase I)IBA
01/2021
1Glycogen Synthase Kinase 3IBA
01/2021
1AcidsIBA
01/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
02/2019
1Galantamine (Galanthamine)FDA LinkGeneric
02/2019
1Transcription Factors (Transcription Factor)IBA
12/2018
1norketamineIBA
10/2018
1KetamineFDA LinkGeneric
10/2018
1Haloperidol (Haldol)FDA LinkGeneric
10/2017
1rhyncophyllineIBA
01/2017
1Protons (Proton)IBA
01/2017
1Inositol (Myoinositol)IBA
01/2017
1tipepidineIBA
02/2016
1beta-Arrestin 1IBA
12/2015
1G-protein-coupled receptor kinase 6IBA
12/2015
1LithiumIBA
12/2014
1Messenger RNA (mRNA)IBA
12/2014
1Fatty Acid-Binding Protein 7IBA
12/2014
1ramelteon (Rozerem)FDA Link
12/2014
1TropomyosinIBA
10/2014
1LigandsIBA
10/2014
1Phosphotransferases (Kinase)IBA
10/2014
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
07/2014
1brain-derived neurotrophic factor precursorIBA
02/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2014
1Paroxetine (Paxil)FDA LinkGeneric
11/2011
1Cilostazol (Pletal)FDA LinkGeneric
10/2011
1Serine (L-Serine)FDA Link
02/2011
1Amino AcidsFDA Link
02/2011
1BenzodiazepinesIBA
11/2010
1Tropisetron (Navoban)IBA
06/2010
1alpha7 Nicotinic Acetylcholine ReceptorIBA
06/2010
1Serotonin (5 Hydroxytryptamine)IBA
06/2008
1N-Methylaspartate (NMDA)IBA
06/2008
15-HT1A Serotonin ReceptorIBA
06/2008
1AntioxidantsIBA
04/2008
1Glutathione (Reduced Glutathione)IBA
04/2008
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2007
1Minocycline (Cyclops)FDA LinkGeneric
09/2007
1MKC 231IBA
09/2007
1Bromodeoxyuridine (BrdU)IBA
09/2006
1Methylphenidate (Ritalin)FDA LinkGeneric
09/2006
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
09/2006
1NRH - quinone oxidoreductase2IBA
06/2005
1QuinonesIBA
06/2005
1serotonin 6 receptorIBA
04/2004

Therapy/Procedure

1Aftercare (After-Treatment)
12/2014
1Therapeutics
10/2012